|
Originally published In Press as doi:10.1074/jbc.M200875200 on February 14, 2002
J. Biol. Chem., Vol. 277, Issue 19, 16913-16919, May 10, 2002
Peroxisome Proliferator-activated Receptor Agonists Inhibit
HIV-1 Replication in Macrophages by Transcriptional and
Post-transcriptional Effects*
Michael M.
Hayes ,
Brian R.
Lane§,
Steven R.
King¶,
David
M.
Markovitz§ , and
Michael J.
Coffey **
From the Divisions of Pulmonary and Critical
Care Medicine, ¶ Rheumatology, and Infectious Diseases
and the § Graduate Program in Cellular and Molecular
Biology, University of Michigan Medical Center, Ann Arbor, Michigan
48109
Previous studies have demonstrated that
cyclopentenone prostaglandins (cyPG) inhibit human
immunodeficiency virus type 1 (HIV-1) replication in various cell
types. We investigated the role of PG in the replication of HIV-1 in
primary macrophages. The cyPG, PGA1 and
PGA2, inhibited HIV-1 replication in acutely infected human
monocyte-derived macrophages (MDM). Because PGA1 and
PGA2 have previously been shown to be peroxisome
proliferator-activated receptor (PPAR ) agonists, we examined the
effect of synthetic PPAR agonists on HIV replication. The PPAR
agonist ciglitazone inhibited HIV-1 replication in a
dose-dependent manner in acutely infected human MDM. In
addition, cyPG and ciglitazone reduced HIV replication in latently
infected and viral entry-independent U1 cells, suggesting an effect at
the level of HIV gene expression. Ciglitazone also suppressed HIV-1
mRNA levels as measured by reverse transcriptase PCR, in
parallel with the decrease in reverse transcriptase activity.
Co-transfection of PPAR wild type vectors and treatment with PPAR
agonists inhibited HIV-1 promoter activity in U937 cells. Activation of
PPAR also decreased HIV-1 mRNA stability following actinomycin D
treatment. In summary, our experimental findings implicate PPAR as
an important factor in the suppression of HIV-1 gene expression in MDM
by cyPG. Thus natural and synthetic PPAR agonists may play a role in
controlling HIV-1 infection in macrophages.
*
This work was supported by National Institutes of Health
Grants AI36685 (to D. M. M.) and HL57885 (to M. J. C.), the General Clinical Research Center at the University of Michigan (Grant MOI-RR00042), the Medical Scientist Training Program of the University of Michigan (National Institutes of Health Grant NIGMS T32GM07863 to
B. R. L.), and funds from the Harvey fellows programs (to
B. R. L.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
To whom correspondence should be addressed: University of Michigan
Medical Center, 6301 MSRB III, 1150 W. Medical Center Dr., Ann
Arbor, MI 48109-0642. Tel.: 734-764-4554; Fax: 734-764-4556; E-mail:
coffeym@umich.edu.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. Huang, S. Y. Eum, I. E Andras, B. Hennig, and M. Toborek
PPAR{alpha} and PPAR{gamma} attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities
FASEB J,
May 1, 2009;
23(5):
1596 - 1606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Horiba, L. B. Martinez, J. L. Buescher, S. Sato, J. Limoges, Y. Jiang, C. Jones, and T. Ikezu
OTK18, a zinc-finger protein, regulates human immunodeficiency virus type 1 long terminal repeat through two distinct regulatory regions
J. Gen. Virol.,
January 1, 2007;
88(1):
236 - 241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Vazquez, T. Greenwell-Wild, N. J. Marinos, W. D. Swaim, S. Nares, D. E. Ott, U. Schubert, P. Henklein, J. M. Orenstein, M. B. Sporn, et al.
Human Immunodeficiency Virus Type 1-Induced Macrophage Gene Expression Includes the p21 Gene, a Target for Viral Regulation
J. Virol.,
April 1, 2005;
79(7):
4479 - 4491.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Si, M.-L. Zhao, A. C. A. Morgan, C. F. Brosnan, and S. C. Lee
15-Deoxy-{Delta}12,14-Prostaglandin J2 Inhibits IFN-Inducible Protein 10/CXC Chemokine Ligand 10 Expression in Human Microglia: Mechanisms and Implications
J. Immunol.,
September 1, 2004;
173(5):
3504 - 3513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Rohr, C. Marban, D. Aunis, and E. Schaeffer
Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells
J. Leukoc. Biol.,
November 1, 2003;
74(5):
736 - 749.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|